242 related articles for article (PubMed ID: 31010842)
1. Treatment of
Follman KE; Morris ME
J Pharmacol Exp Ther; 2019 Jul; 370(1):84-91. PubMed ID: 31010842
[TBL] [Abstract][Full Text] [Related]
2.
Rodriguez-Cruz V; Morris ME
J Pharmacol Exp Ther; 2021 Jul; 378(1):42-50. PubMed ID: 33963018
[TBL] [Abstract][Full Text] [Related]
3. A Novel Monocarboxylate Transporter Inhibitor as a Potential Treatment Strategy for γ-Hydroxybutyric Acid Overdose.
Vijay N; Morse BL; Morris ME
Pharm Res; 2015 Jun; 32(6):1894-906. PubMed ID: 25480120
[TBL] [Abstract][Full Text] [Related]
4. Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of γ-hydroxybutyrate and γ-butyrolactone.
Morse BL; Morris ME
J Pharmacol Exp Ther; 2013 Apr; 345(1):102-10. PubMed ID: 23392755
[TBL] [Abstract][Full Text] [Related]
5. Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells.
Guan X; Rodriguez-Cruz V; Morris ME
AAPS J; 2019 Jan; 21(2):13. PubMed ID: 30617815
[TBL] [Abstract][Full Text] [Related]
6. The Drug of Abuse Gamma-Hydroxybutyric Acid Exhibits Tissue-Specific Nonlinear Distribution.
Felmlee MA; Morse BL; Follman KE; Morris ME
AAPS J; 2017 Dec; 20(1):21. PubMed ID: 29280004
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model.
Guan X; Bryniarski MA; Morris ME
AAPS J; 2018 Nov; 21(1):3. PubMed ID: 30397860
[TBL] [Abstract][Full Text] [Related]
8. AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.
Ovens MJ; Davies AJ; Wilson MC; Murray CM; Halestrap AP
Biochem J; 2010 Jan; 425(3):523-30. PubMed ID: 19929853
[TBL] [Abstract][Full Text] [Related]
9. Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights.
Puri S; Juvale K
Eur J Med Chem; 2020 Aug; 199():112393. PubMed ID: 32388280
[TBL] [Abstract][Full Text] [Related]
10. Drug-drug interaction between diclofenac and gamma-hydroxybutyric acid.
Rodriguez-Cruz V; Ren T; Morris ME
Biopharm Drug Dispos; 2021 Sep; 42(8):351-358. PubMed ID: 34191301
[TBL] [Abstract][Full Text] [Related]
11. Glucose-dependent growth arrest of leukemia cells by MCT1 inhibition: Feeding Warburg's sweet tooth and blocking acid export as an anticancer strategy.
Pivovarova AI; MacGregor GG
Biomed Pharmacother; 2018 Feb; 98():173-179. PubMed ID: 29253765
[TBL] [Abstract][Full Text] [Related]
12. Gamma butyrolactone (GBL) and gamma valerolactone (GVL): similarities and differences in their effects on the acoustic startle reflex and the conditioned enhancement of startle in the rat.
Marinetti LJ; Leavell BJ; Jones CM; Hepler BR; Isenschmid DS; Commissaris RL
Pharmacol Biochem Behav; 2012 Jun; 101(4):602-8. PubMed ID: 22349589
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic modeling of monocarboxylate transporter-mediated toxicokinetic/toxicodynamic interactions between γ-hydroxybutyrate and L-lactate.
Morse BL; Vijay N; Morris ME
AAPS J; 2014 Jul; 16(4):756-70. PubMed ID: 24854892
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.
Morse BL; Chadha GS; Felmlee MA; Follman KE; Morris ME
Am J Drug Alcohol Abuse; 2017 Nov; 43(6):686-693. PubMed ID: 28662343
[TBL] [Abstract][Full Text] [Related]
15. Toxicokinetics/Toxicodynamics of γ-hydroxybutyrate-ethanol intoxication: evaluation of potential treatment strategies.
Morse BL; Morris ME
J Pharmacol Exp Ther; 2013 Sep; 346(3):504-13. PubMed ID: 23814094
[TBL] [Abstract][Full Text] [Related]
16. Toxicokinetic/Toxicodynamic Interaction Studies in Rats between the Drugs of Abuse γ-Hydroxybutyric Acid and Ketamine and Treatment Strategies for Overdose.
Kwatra NV; Morris ME
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34069815
[TBL] [Abstract][Full Text] [Related]
17. Gamma-aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone.
Carai MA; Lobina C; Maccioni P; Cabras C; Colombo G; Gessa GL
J Pharmacol Sci; 2008 Feb; 106(2):199-207. PubMed ID: 18270475
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein.
Ovens MJ; Manoharan C; Wilson MC; Murray CM; Halestrap AP
Biochem J; 2010 Oct; 431(2):217-25. PubMed ID: 20695846
[TBL] [Abstract][Full Text] [Related]
19. [Current knowledge on gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL) and 1 ,4-butanediol (1,4-BD)].
Dematteis M; Pennel L; Mallaret M
Rev Prat; 2012 May; 62(5):669-72. PubMed ID: 22730800
[TBL] [Abstract][Full Text] [Related]
20. Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.
Vijay N; Morris ME
J Pharm Sci; 2014 Oct; 103(10):3310-5. PubMed ID: 25174723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
